Induction of New Aromatic Polyketides from the Marine Actinobacterium Streptomyces griseorubiginosus through an OSMAC Approach
Marine Drugs · 2023
DOI: 10.3390/md21100526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Víctor Rodríguez Martín-Aragón und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomar Microbial Technologies, Parque Tecnológico de León, Parcela M-10.4, Armunia, 24009 León, Spain. Hauptthemen laut MEDLINE: Polyketides, Streptomyces, Biological Products. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MINISTERIO DE CIENCIA E INNOVACION, Agencia Canaria de Investigación, Innovación y Sociedad de la Información, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
Using the OSMAC (One Strain Many Compounds) approach, the actinobacterium Streptomyces griseorubiginosus, derived from an unidentified cnidarian collected from a reef near Pointe de Bellevue in Réunion Island (France), was subjected to cultivation under diverse conditions. This endeavour yielded the isolation of a repertoire of 23 secondary metabolites (1–23), wherein five compounds were unprecedented as natural products (19–23). Specifically, compounds 19 and 20 showcased novel anthrone backbones, while compound 23 displayed a distinctive tetralone structure. Additionally, compounds 21 and 22 presented an unusual naphtho [2,3-c]furan-4(9H)-one chromophore. Interestingly, the detection of all these novel compounds (19–23) was exclusively achieved when the bacterium was cultured in FA-1 liquid medium supplemented with the epigenetic modifier γ-butyrolactone. The elucidation of the structural features of the newfound compounds was accomplished through a combination of HRESIMS, 1D and 2D NMR spectroscopy, as well as QM-NMR (Quantum Mechanical—Nuclear Magnetic Resonance) methods and by comparison with existing literature. Moreover, the determination of the relative configuration of compound 23 was facilitated by employing the mix-J-DP4 computational approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomar Microbial Technologies, Parque Tecnológico de León, Parcela M-10.4, Armunia, 24009 León, Spain.
- Instituto de Productos Naturales y Agrobiología, Consejo Superior de Investigaciones Científicas (IPNA-CSIC), 38206 La Laguna, Tenerife, Spain.
ORCID-Profile: Víctor Rodríguez Martín-Aragón, José M Sánchez López
Förderung
- MINISTERIO DE CIENCIA E INNOVACION
- Agencia Canaria de Investigación, Innovación y Sociedad de la Información
- Ministerio de Ciencia, Innovación y Universidades
- Fondo Social Europeo (Programa Operativo Integrado de Canarias FSE 2014–2020, Eje 3, Tema Prioritario 74–85%)
- Ministerio de Ciencia e Innovación (MICINN) of the Spanish Government for financial support (State Plan for Scientific and Technical Research and Innovation 20…
- Agencia Canaria de Investigación, Innovación y Sociedad de la Información (ACIISI) and Fondo Social Europeo (Programa Operativo Integrado de Canarias FSE 2014–…
Zitieren
APA
Martín-Aragón, V. R., Millán, F. R., Cuadrado, C., Daranas, A. H., Medarde, A. F., & López, J. M. S. (2023). Induction of New Aromatic Polyketides from the Marine Actinobacterium Streptomyces griseorubiginosus through an OSMAC Approach. Marine Drugs. https://doi.org/10.3390/md21100526
Vancouver
Martín-Aragón VR, Millán FR, Cuadrado C, Daranas AH, Medarde AF, López JMS. Induction of New Aromatic Polyketides from the Marine Actinobacterium Streptomyces griseorubiginosus through an OSMAC Approach. Marine Drugs. 2023. doi:10.3390/md21100526
BibTeX
@article{MartnAragn2023,
author = {Martín-Aragón, Víctor Rodríguez and Millán, Francisco Romero and Cuadrado, Cristina and Daranas, Antonio Hernández and Medarde, Antonio Fernández and López, José M Sánchez},
title = {Induction of New Aromatic Polyketides from the Marine Actinobacterium Streptomyces griseorubiginosus through an OSMAC Approach},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21100526}
}
EUVIMED